Todd Cohen

Title: Professor/Chief, Cardiology/Director, Med Device Innovation
Department: College of Osteopathic Medicine, Clinical Specialties
Campus: Long Island
Areas of Expertise: Cardiology, Cardiovascular Disease, Medical Innovation, Medical Entrepreneurship, Internal Medicine, Cardiac Electrophysiology
Education Credentials: M.D.
Industry Credentials: FACC, FHRS
Joined New York Tech: 2019
Todd J. Cohen, M.D., is a triple-boarded (Johns Hopkins, Stanford, and UCSF trained) practicing cardiologist, inventor, educator, and serial entrepreneur.
Cohen built and directed two of the busiest electrophysiology programs on Long Island at North Shore University Hospital and Winthrop University Hospital. He is also the founder and director of the Long Island Heart Rhythm Center, and chief of cardiology and director of medical device innovation at NYITCOM. His hospital affiliations include Mercy Medical Center, St. Joseph Hospital, Good Samaritan Hospital, Mount Sinai Hospital, and Mount Sinai West (St. Luke's - Roosevelt).
As of 2024, Cohen has secured nearly 40 United States patents for his pioneering inventions in electrophysiology, implantable devices, robotics, and other critical areas. Patents for his innovations have been acquired by prominent healthcare technology companies, including Medtronic and Boston Scientific, among others. He is the inventor of EZ-Holder™ an inexpensive sterile, disposable device that functions like a surgical assist, and the EZ-OFF™ system, which gives all operators the ability to manually terminate ablation procedures of every type. An expert in medical device innovation, Cohen is also an enthusiastic and dedicated mentor to future physicians who aspire to be medical inventors.
Cohen has authored many publications, including articles featured in the New England Journal of Medicine, the Journal of the American Medical Association, Circulation, and the Journal of the American College of Cardiology. At NYITCOM's Ehlers-Danlos Syndrome (EDS)/Hypermobility Treatment Center, he has conducted transformative research into the condition, which can be life-threatening if blood vessels or heart tissue are affected. Cohen has served as principal investigator of numerous investigator-initiated studies (including the Pacemaker and Implantable Defibrillator Lead Survival Study) and multicenter trials, including SCD-HeFT and the EnRhythm MRI trial. He also serves on the editorial boards of the Journal of Invasive Cardiology and EP Lab Digest;
In addition, he is an advisor to the Heart Rhythm Society, serves on the advisory board of the Sudden Cardiac Arrest Association, a not-for-profit patient advocacy charity, and serves on the American Board of Internal Medicine Maintenance of Certification Committee as a relevance reviewer.
Recent Projects and Research
- Spearheading a unique comprehensive treatment program focused on putting patient's healthcare first, providing patient-centered education, and creating new ways to treat heart rhythm problems (innovations).
- Assisting faculty and students in both the medical and engineering schools with research and innovation.
Selected Publications
- Handheld Devices to Augment Cardiopulmonary Resuscitation Therapy; Thoughts on the Development of a Completely Implantable Epicardial Leadless Radiofrequency Pacemaker System: Then and Now; Invasive Electrophysiologic Techniques in the Management of Intractable Ventricular Arrhytymias (Cardiac Electrophysiology Review).
Professional Honors and Awards
- U.S. patent issued Dec 4, 2018 (Patent no.10,143,825): Ablation Catheter System for Preventing Damage
- U.S. patent issued Apr 24, 2018 (Patent no. 9,949,784): Ablation Catheter with Safety Feature
- U.S. patent issued Apr 10, 2018 (Patent no. 9,937,002): Method and system for decreasing transthoracic impedance for cardioversion and defibrillation
- U.S. patent issued Oct 25, 2016 (Patent no. 9,474,892): Ablation catheter system with safety features